In modern proteomics, the ability to confidently detect and quantify low-abundant proteins can determine the success of biomarker discovery, target validation, and translational research. At ITSI Biosciences, we routinely support clients across biopharma, academia,...
In today’s competitive and fast-moving drug discovery landscape, the ability to identify, validate, and prioritize the right biological targets is critical. Quantitative proteomics has emerged as a powerful engine driving this process, transforming complex biological...